← Back to Clinical Trials
Recruiting NCT06808373

NCT06808373 The Effect of Hypnosis on Periodontal Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06808373
Status Recruiting
Phase
Sponsor Afyonkarahisar Health Sciences University
Condition Peridontal Disease
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-11-18
Primary Completion 2025-11-18

Trial Parameters

Condition Peridontal Disease
Sponsor Afyonkarahisar Health Sciences University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 20 Years
Max Age 65 Years
Start Date 2024-11-18
Completion 2025-11-18
Interventions
hypnosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Treatment of periodontal diseases relies on the mechanical removal of microbial dental plaque, calculus, and necrotic cementum from root surfaces in both supra- and subgingival areas to control inflammation in periodontal tissues. As in all dental treatments, dental phobia and dental anxiety are common challenges in initial periodontal therapy. Hypnosis is among the traditional non-pharmacological behavior management techniques used to manage stress and improve pain tolerance. It is known that hypnosis is effective in anxiety control in dentistry. The use of salivary levels of inflammatory mediators released during the disease is a valid method for assessing the progression of periodontal disease and healing after treatment. In this study, the effect of hypnosis on healing in patients undergoing Phase I periodontal therapy will be evaluated by comparing the mean differences in cytokine levels between case and control groups

Eligibility Criteria

Inclusion Criteria: Being between the ages of 20-65 Not having any systemic disease Having chronic periodontal disease Having the ability to understand the study and answer questions Exclusion Criteria: Having any systemic disease Being under 20 or over 65 Not having any periodontal disease

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology